Suspected Toxic Megacolon
Severe colitis with systemic toxicity
All Pathways
Colorectal SurgeryEmergency
Toxic Megacolon Management (ASCRS/AGA)
Toxic Megacolon Management (ASCRS/AGA): Suspected Toxic Megacolon → Jalan Diagnostic Criteria → Identify Underlying Cause → Free Perforation? → EMERGENC...
Pathway Overview
12 steps
Algorithm Steps
12 total
01Start 02Action Jalan Diagnostic Criteria
Must have radiographic + clinical criteria
- RADIOGRAPHIC: Colonic diameter >6cm
- PLUS ≥3 of:
- - Fever >38.6°C (101.5°F)
- - Heart rate >120 bpm
- - WBC >10,500 or neutrophilia
- - Anemia
- PLUS ≥1 of:
- - Dehydration
- - Altered mental status
- - Electrolyte disturbance
- - Hypotension
03Action Identify Underlying Cause
Different etiologies, same urgency
- Ulcerative colitis (most common)
- Crohn's colitis
- C. difficile infection
- CMV colitis (immunocompromised)
- Ischemic colitis
- Pseudomembranous colitis
04Decision Free Perforation?
Immediate surgical indication
- Free air on imaging
- Peritonitis on exam
- Septic shock
05Warning EMERGENCY COLECTOMY
No delay - immediate surgery
- Subtotal colectomy
- End ileostomy
- Hartmann's closure of rectum
- Leave rectum for future IPAA
- Do NOT attempt anastomosis
- Do NOT perform proctectomy acutely
06Action Post-Operative Care
ICU and recovery
- ICU monitoring initially
- Wean steroids postop
- Stoma teaching
- Nutrition optimization
- Discuss future options (IPAA vs permanent)
- Pathology review (Crohn's vs UC)
07Outcome Outcomes
Prognosis and long-term
- Surgical mortality: 2-8% (higher with delay)
- Perforation mortality: 20-40%
- Future IPAA rate: 50-70%
- Quality of life generally good with ileostomy
08Action Intensive Medical Therapy
24-72 hour trial maximum
- IV corticosteroids (Hydrocortisone 100mg q8h or Methylpred 60mg/day)
- NPO, NG tube if vomiting
- IV fluids, electrolyte repletion
- DVT prophylaxis (SCD + LMWH)
- C. diff testing and treatment if positive
- Avoid opioids, anticholinergics, antidiarrheals
- Knee-roll positioning q2-4h
- Serial abdominal exams and XRs
09Decision Response to Medical Therapy?
Reassess at 24-48-72 hours
- Improvement: Decreased dilation, fever resolution
- No improvement: Consider rescue therapy or surgery
- Deterioration: Immediate surgery
10Action Rescue Therapy Options
If no response to steroids in 3-5 days
- Infliximab (5mg/kg) - consider accelerated dosing
- Cyclosporine (2-4 mg/kg/day IV)
- Sequential therapy controversial
- Not for perforation/peritonitis
- Still need surgery in 50% at 1 year
11Warning Surgical Indications
Do not delay if criteria met
- Perforation
- Massive hemorrhage
- No improvement in 48-72h
- Clinical deterioration
- Progressive dilation
- Increasing vasopressor requirement
12Action Subtotal Colectomy + End Ileostomy
Procedure of choice
- Remove entire colon to rectosigmoid
- End ileostomy in RLQ
- Hartmann's or mucous fistula
- Preserve rectum for future IPAA
- Laparoscopic if expertise/stability permits
- Avoid proctectomy (preserve options)
- Path rejoins step 06Shared downstream outcome
- Path rejoins step 11Shared downstream outcome
- Path rejoins step 07Shared downstream outcome
Guideline Source
ASCRS Clinical Practice Guidelines for UC + AGA Severe UC Guidelines
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- C. diff vs IBD toxic megacolon may differ in management
- Biologics may delay surgery but not prevent if needed
- Elderly and immunocompromised need modified approach
- Crohn's vs UC may affect pouch candidacy later
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Related Colorectal Surgery Pathways
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Toxic Megacolon Management (ASCRS/AGA)?
The Toxic Megacolon Management (ASCRS/AGA) is a emergency clinical algorithm for Colorectal Surgery. It provides a structured decision tree to guide clinical decision-making, based on ASCRS Clinical Practice Guidelines for UC + AGA Severe UC Guidelines.
What guideline is the Toxic Megacolon Management (ASCRS/AGA) based on?
This algorithm is based on ASCRS Clinical Practice Guidelines for UC + AGA Severe UC Guidelines (DOI: 10.1097/DCR.0000000000001512).
What are the limitations of the Toxic Megacolon Management (ASCRS/AGA)?
Known limitations include: C. diff vs IBD toxic megacolon may differ in management; Biologics may delay surgery but not prevent if needed; Elderly and immunocompromised need modified approach; Crohn's vs UC may affect pouch candidacy later. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Toxic Megacolon Management (ASCRS/AGA) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free